MedPath
NMPA Approval

Recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine

国药准字SJ20170037

April 7, 2022

S20170037

Drug Information

四价人乳头瘤病毒疫苗(酿酒酵母)

佳达修

注射剂

0.5mL/支

生物制品

April 7, 2022

April 6, 2027

Company Information

Applicant Company

Merck, Inc.

126 E. Lincoln Avenue, P.O. Box 2000, Rahway, NJ07065, US

Manufacturing Company

Merck, Inc.

770 Sumneytown Pike, West Point, Pennsylvania 19486, U.S.A.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

四价人乳头瘤病毒疫苗(酿酒酵母) - NMPA 批准文号 | MedPath